Skip to main content
logo
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.360
-0.300 (-11.28%)
At close: Sep 15, 2026, 4:00 PM EDT
2.330
-0.030 (-1.27%)
Pre-market: Sep 16, 2026, 6:10 AM EDT

China SXT Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-6.21-3.3-3.1-5.93-5.74
Depreciation & Amortization
0.140.150.270.250.32
Other Amortization
-0.520.290.340.03
Loss (Gain) From Sale of Assets
-0.01---
Asset Writedown & Restructuring Costs
--0.420.35-
Stock-Based Compensation
5.31-0.350.552.33
Provision & Write-off of Bad Debts
0.130.260.282.880.48
Other Operating Activities
-10.98-0.070.070.94
Change in Accounts Receivable
0.29-0.26-0.320.910.83
Change in Inventory
-0.51-0.3-0.190.410.3
Change in Accounts Payable
-0.69-0.11-0.030.01-0.02
Change in Income Taxes
0.02-0.0200.03-0.03
Change in Other Net Operating Assets
-1.49-0.280.160.060.83
Operating Cash Flow
-4.02-2.35-1.93-0.080.27
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
--0-0.01-0.07-0.06
Sale of Property, Plant & Equipment
-0.07---
Sale (Purchase) of Intangibles
-1.25----
Other Investing Activities
--0.030.060.02
Investing Cash Flow
-1.250.060.03-0.01-0.05

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-7.431.063.722.8
Long-Term Debt Issued
0.520.260.430.31-
Total Debt Issued
0.527.691.54.032.8
Short-Term Debt Repaid
---3.93-2.83-3.81
Long-Term Debt Repaid
-0.38-1.92-0.08-0.03-0.03
Total Debt Repaid
-0.38-1.92-4.01-2.85-3.85
Net Debt Issued (Repaid)
0.145.77-2.511.18-1.04
Issuance of Common Stock
14.292.76-2.193.12
Other Financing Activities
--0.14-0.11-0.43-0.48
Financing Cash Flow
14.438.4-2.622.941.6

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.88-0.07-0.77-1.050.39
Net Cash Flow
10.056.05-5.291.82.21

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-4.02-2.35-1.94-0.150.21
Free Cash Flow Growth
-----
Free Cash Flow Margin
-353.01%-134.83%-100.34%-7.68%7.91%
Free Cash Flow Per Share
----0.10
Levered Free Cash Flow
-4.74-2.57-1.151.782.31
Unlevered Free Cash Flow
-4.7-2.68-1.11.752.31

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
0.020.020.020.010
Cash Income Tax Paid
----0.02
Change in Working Capital
-2.39-0.97-0.381.421.9
SEC Filings: 10-K · 10-Q